NZ Infectious Diseases Research Review Issue 32

In this issue:
  -  Ceftriaxone as definitive therapy for MSSA bacteraemia
  -  Empirical vs. pre-emptive antifungals in high-risk neutropenic patients on fluconazole prophylaxis
  -  Antibiotic treatment duration in P. aeruginosa ventilatorassociated pneumonia
  -  Syphilis RPR titre changes between diagnosis and treatment
  -  Piperacillin-tazobactam vs. cefepime/carbapenem for immunocompromised, cefoxitin-nonsusceptible bacteraemia
  -  Highly vs. less bioavailable oral antibiotics for gram-negative BSIs
  -  Hospital-acquired BSIs in ICUs
  -  Postexposure doxycycline to prevent bacterial STIs
  -  Treatment strategies for rifampicin-susceptible TB
  -  Azithromycin to prevent sepsis or death in women planning vaginal delivery

Please login below to download this issue (PDF)

Subscribe